Effects of diet-induced obesity on protein expression in insulin signaling pathways of skelet al muscle in male Wistar rats

International Journal of General Medicine

Volumn 5, Issue , 2012, Pages 573-582

  Fatani, Sameer ^a   Abubakari, Abdul Razak ^b   Itua, Imose ^b   Wong, Christopher ^c   Thomas, Cecil ^c   Naderali, Ebrahim K ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LIVERPOOL HOPE UNIVERSITY   (United Kingdom)

^c ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Diet induced obesity; Fenofibrate; Insulin signaling; Intramuscular lipids; Muscle

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C BETA; PROTEIN SHC; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FAT CONTENT; GASTROCNEMIUS MUSCLE; GLUCOSE HOMEOSTASIS; HORMONE ACTION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPID ANALYSIS; LIPID STORAGE; MALE; MUSCLE LEVEL; NONHUMAN; OBESITY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UPREGULATION; WEIGHT GAIN;

EID: 84877143750     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S31819     Document Type: Article

References (45)

1. Dohm G, Tapscott E, Poruies W, et al. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest. 1988;82:486-494.
2. Fatani S, Itua I, Clark P, Wong C, Naderali EK. The effects of diet-induced obesity on hepatocyte insulin signaling pathways and induction of non-alcoholic liver damage. Int J Gen Med. 2011;4:211-219.
3. Shulman GI. Cellular mechanisms of insulin resistance in humans. Am J Cardiol. 1999;84:3J-10J.
4. McGarry JD. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51:7-18.
5. Despres JP, Lam Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-958.
6. Schmitz-Peiffer C. Protein kinase C and lipid-induced insulin resistance in skelet al muscle. Ann N Y Acad Sci. 2002;967:146-157.
7. Cooney GJ, Thompson AL, Furler SM, Ye J, Kraegen EW. Muscle long chain acyl CoA esters and insulin resistance. Ann N Y Acad Sci. 2002;967:196-207.
8. Bossenmaier B, Mosthaf L, Mischak H, Ullrich A, Haring H. Protein kinase C isoforms beta 1 and beta 2inhibit the tyrosine kinase activity of the insulin receptor. Diabetologia. 1997;40:863-866.
9. Itani SI, Zhou Q, Pories WJ, Macdonald KG, Dohm GL. Involvement of protein kinase C in human skelet al muscle insulin resistance and obesity. Diabetes. 2000;49:1353-1358.
10. Long S, Pekala P. Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4gene transcription in 3T3-L1 adipocytes. Biochem J. 1996;319:179-184.
11. Chavez JA, Knotts TA, Wang LP, et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem. 2003;278:10297-10303.
12. Bastard J, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17:4-12.
13. Oakes N, Bell K, Furler S, et al. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA. Diabetes. 1997;46:2022-2028.
14. Monzillo L, Hamdy O, Horton E, et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res. 2003;11:1048-1054.
15. Ye JM, Doyle PJ, Iglesias MA, Watson DG, Cooney GJ, Kraegen EW. Peroxisome proliferator-activated receptor (PPAR) alpha activation lowers muscle lipids and improves insulin sensitivity in high fate-fed rats: comparison with PPAR-gamma activation. Diabetes. 2001;50: 411-417.
16. Lee HJ, Choi SS, Park MK, et al. Fenofibrate lowers abdominal and skelet al adiposity and improves insulin sensitivity in OLETF rats. Biochem Biophys Res Commun. 2002;296:293-299.
17. Hulver MW, Berggren JR, Cortright RN, et al. Skelet al muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab. 2003;284:E741-E747.
18. Hegarty BD, Furler SM, Ye J, Cooney GJ, Kraegen EW. The role of intramuscular lipid in insulin resistance. Acta Physiol Scand. 2003;178: 373-383.
19. Naderali EK, Brown MJ, Pickavance LC, Wilding JP, Doyle PJ, Williams G. Dietary obesity in the rat induces endothelial dysfunction without causing insulin resistance: a possible role for triacylglycerols. Clin Sci (Lond). 2001;101:499-506.
20. Sampson SR, Cooper DR. Specific protein kinase C isoforms as transducers and modulators of insulin signaling. Mol Genet Metab. 2006;89:32-47.
21. Houmard J, Pories W, Dohm G. Is there a metabolic program in the skelet al muscle of obese individuals? J Obes. 2011;2011:250496.
22. Sesti G. Pathophysiology of insulin resistance. Best Pract Res Clin Endocrinol Metab. 2006;20:665-679.
23. Zhang L, Keung W, Samokhvalov V, Wang W, Lopaschuk GD. Role of fatty acid uptake and fatty acid [beta]-oxidation in mediating insulin resistance in heart and skelet al muscle. Biochim Biophys Acta. 2010;1801:1-22.
24. Bai X, Li H, Yang W, et al. Effects of fenofibrate on gene expression of carnitine palmitoyltransferase 1in liver and skelet al muscle and its influence on insulin sensitivity. Zhonghua Yi Xue Za Zhi. 2008;88:268-270. Chinese.
25. Selivanov VA, Votyakova TV, Pivtoraiko VN, et al. Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain. PLoS Comput Biol. 2011;7:e1001115.
26. Del Carlo M, Loeser RF. Chondrocyte cell death mediated by reactive oxygen species-dependent activation of PKC-betaI. Am J Physiol Cell Physiol. 2006;290:C802-C811.
27. Lores-Arnaiz S, Travacio M, Monserrat AJ, Cutrin JC, Llesuy S, Boveris A. Chemiluminescence and antioxidant levels during peroxisome proliferation by fenofibrate. Biochim Biophys Acta. 1997;1360: 222-228.
28. Jiao HL, Zhao BL. Cytotoxic effect of peroxisome proliferator fenofibrate on human HepG2 hepatoma cell line and relevant mechanisms. Toxicol Appl Pharm. 2002;185:172-179.
29. Jiao HL, Ye P, Zhao BL. Protective effects of green tea polyphenols on human HepG2cells against oxidative damage of fenofibrate. Free Radic Biol Med. 2003;35:1121-1128.
30. Kim YB, Kotani K, Ciaraldi TP, Henry RR, Kahn BB. Insulin-stimulated protein kinase C activity is reduced in skelet al muscle of humans with obesity and type 2 diabetes. Diabetes. 2003;52:1935-1942.
31. Farese RV, Sajan MP, Standaert ML. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes. Exp Biol Med. 2005;230:593-605.
32. Chow L, From A, Seaquist E. Skelet al muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction. Metabolism. 2010;59:70-85.
33. Vazquez M, Silvestre J, Prous J. Experimental approaches to study PPAR gamma agonists as antidiabetic drugs. Methods Find Exp Clin Pharmacol. 2002;24:515-523.
34. Bhattacharya S, Dey D, Roy S. Molecular mechanism of insulin resistance. J Biosci. 2007;32:405-413.
35. Saini V. Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J Diabetes. 2010;1:68-75.
36. Barbour LA, Shao J, Qiao L, et al. Human placental growth hormone increases expression of the P85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skelet al muscle. Endocrinology. 2004;145:1144-1150.
37. Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM. Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skelet al muscle. Diabetes. 2005;54:2351-2359.
38. Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest. 1999;104:733-741.
39. Chun KH, Choi KD, Lee DH, et al. In vivo activation of ROCK1 by insulin is impaired in skelet al muscle of humans with type 2 diabetes. Am J Physiol Endocrinol Metab. 2010;300:E536-E542.
40. Kubota T, Yano T, Fujisaki K, Itoh Y, Oishi R. Fenofibrate induces apoptotic injury in cultured human hepatocytes by inhibiting phosphorylation of Akt. Apoptosis. 2005;10:349-358.
41. Grabacka M, Plonka PM, Urbanska K, Reiss K. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt. Clin Cancer Res. 2006;12:3028-3036.
42. Moon JH, Lee JY, Kang SB, et al. Dietary monounsaturated fatty acids but not saturated fatty acids preserve the insulin signaling pathway via IRS-1/PI3K in rat skelet al muscle. Lipids. 2010;45:1109-1116.
43. Páez-Espinosa EV, Rocha EM, Velloso LA, Boschero AC, Saad MJ. Insulin-induced tyrosine phosphorylation of Shc in liver, muscle and adipose tissue of insulin resistant rats. Mol Cell Endocrinol. 1999;156: 121-129.
44. Fatani S, Naderali EK, Panchiani S, Shah F, Wong C. The effects of dietary obesity on protein expressions of insulin signaling pathway in rat aorta. Drug Discov Ther. 2008;2:254-261.
45. Valerio A, Cardile A, Cozzi V, et al. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest. 2006;116:2791-2798.